Clinical Report: Interventional Valve-Enhancing Trabeculotomy

Overview

The interventional valve-enhancing trabeculotomy (iVEnT) is a novel, minimally invasive glaucoma surgery aimed at enhancing physiologic outflow by preserving the intracanalicular structures of Schlemm’s canal. Early clinical experiences suggest that this technique may improve intraocular pressure (IOP) management in glaucoma patients.

Background

Glaucoma management has evolved significantly over the past two decades, with a shift towards minimally invasive techniques that enhance natural aqueous drainage. Traditional surgeries often bypass the natural outflow system, which can lead to complications. The introduction of iVEnT represents an innovative approach that aims to restore and enhance physiologic outflow, potentially improving surgical outcomes for patients with glaucoma.

Data Highlights

No numerical data or trial results were provided in the article.

Key Findings

• The iVEnT procedure aims to cleave the trabecular meshwork while preserving the function of the valves within Schlemm’s canal.
• This technique is designed to enhance pulsatile outflow rather than relying solely on bulk flow.
• Microspatulas specifically designed for iVEnT minimize trauma to the angle during surgery.
• Early clinical experiences indicate variability in IOP reduction, suggesting that factors beyond the trabecular meshwork influence surgical success.
• The procedure builds on the principles established by gonioscopy-assisted transluminal trabeculotomy (GATT).

Clinical Implications

Surgeons may consider incorporating iVEnT into their surgical repertoire for patients with open-angle glaucoma, particularly those with early disease. The technique's focus on preserving natural outflow pathways could lead to improved IOP management and reduced reliance on medications.

Conclusion

The iVEnT procedure represents a promising advancement in glaucoma surgery, emphasizing the importance of enhancing physiologic outflow. Further studies are needed to validate its efficacy and long-term outcomes.

References

1. Ophthalmology Management, 2025 -- Interventional Valve-Enhancing Trabeculotomy
2. British Journal of Ophthalmology, 2025 -- Terminology and guidelines for glaucoma, 6th Edition
3. Ophthalmology Management, 2007 -- Glaucoma Surgery: One-Year Results of the Tube vs. Trabeculectomy (TVT) Study
4. Clinical Research in Cardiology — Transcatheter Replacement of the Tricuspid Valve-in-Valve in Two Cases of Ebstein Anomaly: Technical Insights
5. Ophthalmology Management — Glaucoma Surgery: One-Year Results of the Tube vs. Trabeculectomy (TVT) Study
6. Clinical Research in Cardiology — Impact of Preexisting Right Ventricular Remodeling on Symptoms and Prognosis Following Transcatheter Repair of the Tricuspid Valve
7. European Glaucoma Society – Terminology and guidelines for glaucoma, 6th Edition | British Journal of Ophthalmology
8. Five-Year Visual Field Outcomes of the
9. Ophthalmology Management • Glaucoma Physician November 2025 • Interventional Valve-Enhancing Trabeculotomy